Pulmonary-disorders
Novel Coronavirus (COVID-19)
Guidelines of Bangladesh.
The guidelines for the diagnosis,
treatment, and control of the coronavirus disease (COVID-19).
The COVID-19 pandemic has presented challenges in management and
follow-up in common respiratory diseases such as asthma.
This review will discuss the current recommendations regarding asthma and
COVID-19 based on best available evidence at this time. RemoveAvailable Brand
Montelukast is used to control
and prevent symptoms caused by asthma (such as wheezing and shortness of
breath). It is also used before exercise to prevent breathing problems during
exercise (bronchospasm).Montelukast is also used to
relieve symptoms of hay fever and allergic rhinitis (such as sneezing,
stuffy/runny/itchy nose).
Common Ast...
Montelukast is used to control and prevent symptoms caused by asthma. It is also used before exercise to prevent breathing problems during exercise (bronchospasm).Asthma Symptoms:Montelukast recommended dose is once a day in the evening and it’s important to take it regularly even when patient have no symptoms.Note: Montelukast is not a rescue medi...
Causes of chronic productive cough
A chronic ‘productive’ or ‘wet’ cough is a common presenting complaint for patients.The definition of a “chronic productive cough” was considered to be a cough regularly leading to the expectoration of sputum with the same duration as the standard definition of chronic cough i.e. more than 8 weeks....
In patients with severe or critical Coronavirus disease 2019 (COVID-19) manifestations, a thromboinflammatory syndrome, with diffuse microvascular thrombosis, is increasingly evident as the final step of pro-inflammatory cytokines storm. Actually, no proven effective therapies for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) i...
Baricitinib plus remdesivir was superior to remdesivir alone in reducing
recovery time and accelerating improvement in clinical status among
patients with Covid-19, notably among those receiving high-flow oxygen
or noninvasive ventilation. The combination was associated with fewer
serious adverse events.
The U.S. Food and Drug
Administration issued an emergency use authorization (EUA) for the drug
baricitinib, in combination with remdesivir, for the treatment of suspected or
laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two
years of age or older requiring supplemental oxygen, invasive mechanical...
National guidelines version 8th on clinical management of Coronavirus
disease by Disease Control Division, Directorate General of Health
Services, Ministry of Health & Family Welfare & Government of the
People's Republic of Bangladesh.
The guideline includes clinical management of COVID-19 and
is updated with the latest evide...
An Aid to the Management of
COVID-19 in Bangladesh: “Lessons from the western experience” New 5th Edition
This book is a small effort by
some highly-motivated Bangladeshi doctors living in the UK and the USA to
supplement local guidelines in Bangladesh. This will hopefully enable local
experts in Bangladesh to be kept updated...
National guidelines on clinical management of Coronavirus disease by Disease Control Division, Directorate General of Health Services, Ministry of Health & Family Welfare & Government of the People's Republic of Bangladesh.The guideline includes clinical management of COVID-19 and is updated with the latest evidence and the WHO guidelines.
